×

Get the Prostate Cancer Patient Guide as a digital download or free mailed copy.

Click here.

Alternative Endpoints: Results that Potentially Accelerate Phase 3 Clinical Trials in Metastatic Hormone-Sensitive Prostate Cancer

Alternative Endpoints: Results that Potentially Accelerate Phase 3 Clinical Trials in Metastatic Hormone-Sensitive Prostate Cancer

Clinical trials can bring life-extending and potentially curative new treatments to patients with cancer. They play a vital role in determining the safety and efficacy of investigational treatments, generating data...Read More

Baseball_dad_kid_745x510

Tips to “Keep Dad In the Game”

June is a busy month. The baseball season is in full swing. Men’s Health Week is June 13-19, with Father’s Day on June 19. During the Home Run Challenge, May...Read More

AACR_Clock_DNA_745x510

Research Update from AACR 2022, Part 2

Research Update from AACR 2022, Part 2 The American Association for Cancer Research Annual Meeting 2022 was held in New Orleans in April. Dr. Andrea Miyahira, PCF’s Director of Global...Read More

Cancercellattackedbylymphocytes_745x510

Research Update from AACR 2022, Part 1: Spotlight on Immunotherapy

The American Association for Cancer Research Annual Meeting was held in New Orleans in April. Dr. Andrea Miyahira, PCF’s Director of Global Research and Scientific Communications, has identified key updates...Read More

Salad_745x510

Healthy Eating On the Go: Do the Best You Can

We get a lot of questions about what to eat when you’re traveling, or when you’re at an event and don’t have a lot of healthy options. During the pandemic,...Read More

NMHM_745x510

What is National Minority Health Month?

National Minority Health Month is observed each year in April to raise awareness of health disparities among racial and ethnic minority communities and spur action to overcome these injustices. The...Read More

TestTubes_745x510

Highlights of ASCO GU 2022, Part 2

Informing care for intermediate-risk cancer, a new imaging tracer, and understanding the effects of PSA screening recommendations Clinicians and researchers gathered last month at the American Society of Clinical Oncology...Read More

Imaging_745x510

Breaking News: First-in-Class Radioligand Therapy Approved for Advanced Prostate Cancer

What this means for patients: Today, a new treatment known as 177lutetium-PSMA-617 (Lu-PSMA; trade name Pluvicto®) was approved by the FDA for certain patients with advanced prostate cancer. This medicine delivers a...Read More

Doctor_Hands_745x510

How PCF is Furthering Health Equity and Combating Prostate Cancer Disparities

In the U.S., 1 in 8 men in their lifetime will be diagnosed with prostate cancer. But the disease does not affect all men equally. 1 in 6 Black men...Read More

Brussels_745x510

Roasted Spring Brussels Sprouts

It’s spring. That means the grocery stores will begin to fill with a glorious abundance of seasonal fruits and vegetables. For some, April also means a family gathering filled with...Read More